Citation 103918

GOREN,N: WOERDENBAG,HJ: BOZOK-JOHANSSON,C:. (1996). CYTOTOXIC AND ANTIBACTERIAL ACTIVITIES OF SESQUITERPENE LACTONES ISOLATED FROM TANACETUM PRAETERITUM SUBSP. PRAETERITUM.. 62(5)

Citation Details

Title	CYTOTOXIC AND ANTIBACTERIAL ACTIVITIES OF SESQUITERPENE LACTONES ISOLATED FROM TANACETUM PRAETERITUM SUBSP. PRAETERITUM.
Authors	GOREN,N: WOERDENBAG,HJ: BOZOK-JOHANSSON,C:
Year	1996
Volume	62
Issue	5

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Tanacetum praeteritum (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARMEFOLIN,3-ALPHA-PEROXY:	None
2	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PRAETERITENOLIDE	None
3	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARGLANINE	None
4	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LUDOVICIN B	None
5	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	COSTIC ACID,ISO: 1-ALPHA-6-ALPHA-DIHYDROXY: METHYL ESTER	None
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COSTIC ACID,ISO: 1-ALPHA-6-ALPHA-DIHYDROXY: METHYL ESTER	WEAK ACTIVITY
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COSTIC ACID,ISO: 1-ALPHA-6-ALPHA-DIHYDROXY: METHYL ESTER	WEAK ACTIVITY
8	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARGLANINE,1-DEOXO: 1-ALPHA-HYDROXY:	None
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARGLANINE,1-DEOXO: 1-ALPHA-HYDROXY:	WEAK ACTIVITY
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARGLANINE,1-DEOXO: 1-ALPHA-HYDROXY:	WEAK ACTIVITY
11	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DOUGLANIN	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DOUGLANIN	WEAK ACTIVITY
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DOUGLANIN	WEAK ACTIVITY
14	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SANTAMARIN	None
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SANTAMARIN	WEAK ACTIVITY
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SANTAMARIN	WEAK ACTIVITY
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	REYNOSIN	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	REYNOSIN	WEAK ACTIVITY
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	REYNOSIN	WEAK ACTIVITY
20	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TATRIDIN B,1-EPI:	None
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TATRIDIN B,1-EPI:	WEAK ACTIVITY
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TATRIDIN B,1-EPI:	WEAK ACTIVITY
23	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LUDOVICIN A	None
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LUDOVICIN A	WEAK ACTIVITY
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LUDOVICIN A	WEAK ACTIVITY
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LUDOVICIN A	INACTIVE
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LUDOVICIN A	INACTIVE
28	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LUDOVICIN A	INACTIVE
29	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LUDOVICIN A	INACTIVE
30	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARMEXIN	None
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARMEXIN	WEAK ACTIVITY
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARMEXIN	WEAK ACTIVITY
33	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARMEFOLIN	None
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARMEFOLIN	WEAK ACTIVITY
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARMEFOLIN	WEAK ACTIVITY
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ARMEFOLIN	INACTIVE
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ARMEFOLIN	INACTIVE
38	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ARMEFOLIN	INACTIVE
39	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ARMEFOLIN	INACTIVE
40	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARMEXIFOLIN	None
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARMEXIFOLIN	ACTIVE
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARMEXIFOLIN	ACTIVE
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ARMEXIFOLIN	INACTIVE
44	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ARMEXIFOLIN	INACTIVE
45	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ARMEXIFOLIN	INACTIVE
46	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ARMEXIFOLIN	INACTIVE
47	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	REYNOSIN,3-ALPHA-HYDROXY:	None
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	REYNOSIN,3-ALPHA-HYDROXY:	WEAK ACTIVITY
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	REYNOSIN,3-ALPHA-HYDROXY:	WEAK ACTIVITY
50	Not specified	ISOLATION AND IDENTIFICATION OF	TATRIDIN A	None
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TATRIDIN A	ACTIVE
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TATRIDIN A	ACTIVE
53	Not specified	ISOLATION AND IDENTIFICATION OF	TAMIRIN	None
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAMIRIN	ACTIVE
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAMIRIN	ACTIVE
56	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TAMIRIN	INACTIVE
57	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TAMIRIN	INACTIVE
58	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TAMIRIN	INACTIVE
59	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TAMIRIN	INACTIVE

Citation 103918

Citation Details

Summary

Organisms and Their Experiments (1)

Tanacetum praeteritum (ASTERACEAE)

Show SPARQL Queries (1)

Query 1